Boen (001366)

Search documents
播恩集团:独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
2023-08-24 11:11
独立董事意见 独立董事意见 播恩集团股份有限公司独立董事 关于第三届董事会第三次会议相关事项的独立意见 根据《公司法》、播恩集团股份有限公司(以下简称"公司")的《独立董 事工作制度》、《公司章程》等文件规定,作为公司的独立董事,本着认真、负 责的态度,基于独立、审慎、客观的立场,我们对公司第三届董事会第三次会议 审议的相关事项进行了认真审核,并发表如下独立意见: 一、关于公司 2023 年半年度募集资金存放与使用情况的专项报告的独立意 见 我们认为:公司董事会编制的《2023 年半年度募集资金存放与使用情况的 专项报告》真实、准确、完整地反映了公司 2023 年半年度募集资金存放与使用 的实际情况,审议程序符合有关法律法规及《公司章程》的规定。公司 2023 年 半年度募集资金的存放和使用符合《上市公司监管指引第 2 号——上市公司募集 资金管理和使用的监管要求》《深圳证券交易所上市公司自律监管指引第 1 号— —主板上市公司规范运作》等有关规定,不存在募集资金存放与使用违规的情形, 亦不存在损害公司及全体股东特别是中小股东利益的情形。 二、关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项 说明 ...
播恩集团:关于董事长代行董事会秘书职责的公告
2023-08-24 11:11
证券代码:001366 证券简称:播恩集团 公告编号:2023-049 根据《深圳证券交易所股票上市规则》有关规定,董事会秘书空缺期间超过 三个月之后,董事长应当代行董事会秘书职责,直至公司正式聘任董事会秘书。 因此,公司于 2023 年 8 月 24 日召开公司第三届董事会第三次会议,审议通过了 《关于董事长代行董事会秘书的议案》,自 2023 年 8 月 24 日起,由公司董事长 邹新华先生代行董事会秘书职责,直至公司正式聘任董事会秘书。公司将严格按 照相关法律法规和《公司章程》等规定,尽快完成董事会秘书的聘任工作并及时 公告。 二、董事长邹新华先生代行董事会秘书职责期间的联系方式 1 公司董事长邹新华先生代行董事会秘书职责期间的联系方式如下: 播恩集团股份有限公司 关于董事长代行董事会秘书职责的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 一、董事长代行董事会秘书职责情况 播恩集团股份有限公司(以下简称"公司")于 2023 年 5 月 24 日召开了第 三届董事会第一次会议,审议通过了《关于指定董事代行董事会秘书职责的议案》, 在公司董事会秘书 ...
播恩集团:半年报监事会决议公告
2023-08-24 11:11
证券代码:001366 证券简称:播恩集团 公告编号:2023-048 播恩集团股份有限公司 第三届监事会第二次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 二、监事会会议审议情况 1、会议以 3 票同意、0 票反对、0 票弃权的结果,审议通过《2023 年半 年度报告及其摘要》。 一、监事会会议召开情况 1、会议通知的时间和方式:本次会议通知于 2023 年 8 月 14 日以电子邮件 方式发出。 2、会议的时间、地点和方式:本次会议于 2023 年 8 月 24 日在播恩集团股 份有限公司(以下简称"公司")广州分公司会议室以现场结合通讯的方式召开。 3、会议出席情况:本次会议应出席监事 3 名,实际出席监事 3 名。 4、本次会议由监事会主席曾庆昌先生主持。 5、本次会议的召开符合《公司法》及《公司章程》的规定,会议决议合法、 有效。 2023 年 8 月 25 日 经审议,与会监事认为:公司董事会编制和审核的《2023 年半年度报告》 及其摘要的程序符合法律法规和中国证券监督管理委员会规范性文件的规定,报 告内容真实、准确、完整地反映了 ...
播恩集团:半年度非经营性资金占用及其他关联资金往来情况汇总表
2023-08-24 11:11
播恩集团股份有限公司 第 1 页 共 2 页 | | 广州播恩 维生 素有限公司 | 子公司 | 其他应收款 | 2,030.21 | 12,056.47 - | | 1,702.00 | 12,384.68 往来款 | | 非经营性往来 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 上市公司的子公司 | 兰州播恩 生物 | 子公司 | 其他应收款 | 0.03 | 3,000.00 - | | 3,000.00 | 0.03 往来款 | | 非经营性往来 | | | 技术有限公司 | | | | | | | | | | | | 广州八维 生物 技术有限公司 | 子公司 | 其他应收款 | 1,983.34 | 60.00 - | | 0.00 | 2,043.34 往来款 | | 非经营性往来 | | 及其附属企业 | | | | | | | | | | | | | 浙江播恩 生物 技术有限公司 | 子公司 | 其他应收款 - | | 2,303.36 - | | 2,300.28 | 3.08 | 往来款 | ...
播恩集团:播恩集团业绩说明会、路演活动信息
2023-05-19 11:11
证券代码: 001366 证券简称:播恩集团 播恩集团股份有限公司投资者关系活动记录表 编号:2023-001 | 投资者关系活动 | □特定对象调研 分析师会议 □ | | --- | --- | | 类别 | 媒体采访 业绩说明会 □ √ | | | □ 新闻发布会 □ 路演活动 | | | □ 现场参观 | | | □ 其他 (请文字说明其他活动内容) | | 参与单位名称及 | 通过全景网参与江西辖区上市公司 年投资者网上集体接待 2023 | | 人员姓名 | 日活动的投资者 | | 时间 | 2023 年 5 月 19 日 (周五) 下午 14:30~17:00 | | 地点 | 全景网 https://rs.p5w.net/ | | 上市公司接待人 | 公司副总经理、董秘项帅先生;董事、财务总监徐晔先生;证券 | | 员姓名 | 事务代表王美恒先生 | | | 投资者提出的问题及公司回复情况 | | | 公司就投资者在本次说明会中提出的问题进行了回复: | | | 1、公司未来发展战略是什么,会做行业并购吗? | | | 尊敬的投资者您好,公司秉承"传播农业智慧,提升生命品 | | | 质"的企 ...
播恩集团(001366) - 关于参加江西辖区上市公司2023年投资者网上集体接待日活动的公告
2023-05-15 10:01
证券代码:001366 证券简称:播恩集团 公告编号:2023-039 1 播恩集团股份有限公司 关于参加江西辖区上市公司2023年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流,播恩集团股份有限公司(以下简称"公 司")将参加由江西证监局、江西省上市公司协会与深圳市全景网络有限公司联 合举办的"2023 年江西辖区上市公司投资者集体接待日活动",现将相关事项 公告如下: 本次活动将采用网络远程的方式举行,投资者可登录"全景路演"网站 ( https://rs.p5w.net ),或关注微信公众号:全景财经,或下载全景路演 APP, 参与本次互动交流,活动时间为 2023 年 5 月 19 日(周五)14:30-17:00。 本次参与人员为公司董事兼财务总监徐晔先生、副总经理兼董事会秘书项帅 先生、证券事务代表王美恒先生。届时公司参会人员将在线就公司 2022 年度业 绩、公司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等投资 者关心的问题,与投资者进行沟通与交流,欢迎广大投资者踊跃 ...
播恩集团(001366) - 2023 Q1 - 季度财报
2023-04-24 16:00
Financial Performance - The company's revenue for Q1 2023 reached ¥390,742,547.86, representing a year-on-year increase of 29.70% compared to ¥301,263,110.63 in the same period last year [4] - Net profit attributable to shareholders was ¥18,523,771.86, a significant increase of 1,426.90% from ¥1,213,158.32 in the previous year [4] - The net profit after deducting non-recurring gains and losses was ¥13,451,916.09, up 2,934.47% from ¥443,304.15 year-on-year [4] - The total operating revenue for Q1 2023 was RMB 390,742,547.86, an increase of 29.6% compared to RMB 301,263,110.63 in the same period last year [18] - The total operating costs for Q1 2023 were RMB 373,092,113.13, up from RMB 299,266,831.52, reflecting a year-over-year increase of 24.7% [18] - Operating profit reached CNY 21,597,474.27, compared to CNY 1,895,617.58 in the previous year, marking an increase of about 1,137% [19] - The total comprehensive income for the period was CNY 18,523,771.86, significantly higher than CNY 1,213,158.32 from the previous year [20] Cash Flow and Assets - The net cash flow from operating activities improved by 64.13%, reaching -¥29,483,473.92, compared to -¥82,191,319.03 in the previous year [4] - The company's cash and cash equivalents increased significantly to RMB 433,951,090.32 from RMB 150,755,832.56 at the beginning of the year, representing a growth of 187.5% [14] - The cash flow from operating activities showed a net outflow of CNY 29,483,473.92, an improvement from a net outflow of CNY 82,191,319.03 in the previous year [21] - The company reported cash and cash equivalents at the end of the period amounting to CNY 431,104,090.32, compared to CNY 53,430,728.27 at the end of the previous year, indicating a substantial increase [22] - The total assets at the end of the reporting period were ¥1,058,730,623.57, an increase of 43.34% from ¥738,593,191.57 at the end of the previous year [4] - The total assets of the company reached RMB 1,058,730,623.57, up from RMB 738,593,191.57, indicating a growth of 43.4% [16] - The total liabilities decreased to RMB 199,728,046.43 from RMB 217,169,422.58, a reduction of 8.0% [16] Shareholder Equity - Shareholders' equity attributable to the parent company increased by 64.74% to ¥859,002,577.14 from ¥521,423,768.99 at the end of the previous year [4] - The equity attributable to shareholders increased to RMB 859,002,577.14 from RMB 521,423,768.99, reflecting a growth of 64.6% [16] Government Support and Other Income - The company received government subsidies amounting to ¥5,569,917.54, contributing to a 533.51% increase in other income compared to the previous year [8] Market and Product Development - The company is focusing on expanding its market presence and enhancing product development, although specific new products or technologies were not detailed in the report [15] - The company did not report any significant new product launches or technological advancements during this quarter [23] Research and Development - Research and development expenses for Q1 2023 were RMB 7,662,231.91, compared to RMB 6,568,950.73 in the previous year, an increase of 16.7% [18] Return on Equity - The weighted average return on equity was 2.91%, up from 0.27% in the previous year [4] Financing Activities - The company reported a 1422.88% increase in net cash flow from financing activities, primarily due to funds raised from the initial public offering [9] - The company raised CNY 344,262,000.00 through financing activities, a notable increase from CNY 22,624,000.00 in the prior year [22]
播恩集团(001366) - 2022 Q4 - 年度财报
2023-04-11 16:00
Financial Performance - The company's operating revenue for 2022 was ¥1,709,388,797.19, a decrease of 3.47% compared to ¥1,770,921,679.98 in 2021[27]. - The net profit attributable to shareholders for 2022 was ¥77,190,947.29, down 14.19% from ¥89,953,252.34 in 2021[27]. - The net cash flow from operating activities was ¥43,726,136.35, a decline of 11.12% from ¥49,197,336.42 in 2021[27]. - The total assets at the end of 2022 were ¥738,593,191.57, an increase of 30.61% from ¥565,483,694.75 at the end of 2021[27]. - The basic earnings per share for 2022 were ¥0.64, down 14.67% from ¥0.75 in 2021[27]. - The weighted average return on equity was 16.00% in 2022, a decrease of 6.45% from 22.45% in 2021[27]. - The company reported a net profit of RMB 59,916,183.43 for the year 2022, with a total distributable profit of RMB 262,641,495.28 after accounting for statutory reserves[125]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the fiscal year, representing a 20% year-over-year growth[155]. Dividend Policy - The company reported a cash dividend of 1.8 RMB per 10 shares for the 2022 fiscal year, with no stock bonus[14]. - The cash dividend distribution plan proposes a cash dividend of RMB 1.8 per 10 shares, amounting to a total cash dividend of RMB 28,922,400.00, which represents 100% of the profit distribution total[126]. - The board approved a dividend payout of 0.5 billion RMB, reflecting a commitment to returning value to shareholders[156]. - The company implements a stable profit distribution policy, emphasizing cash dividends, with a minimum annual cash dividend amount not less than 10% of the distributable profit[149]. - The company plans to maintain a cumulative cash dividend distribution of no less than 30% of the average distributable profit over the last three years[149]. Market and Industry Trends - The feed industry in China is experiencing stable growth, with a focus on industry consolidation through mergers and capacity expansion, leading to increased market concentration and scale[38]. - The cyclical nature of the feed industry is heavily influenced by pig prices, which are affected by supply and demand dynamics, with core indicators including the number of breeding sows[40]. - The company plans to enhance production capacity to meet increasing market demand, particularly in the pig farming sector[80]. - Boen Group aims to expand its market presence by targeting large-scale breeding farms and introducing new product combinations[81]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of the next fiscal year[106]. Research and Development - The company has established a robust R&D system, collaborating with universities and research institutions to enhance its innovation capabilities and address key technical challenges[50]. - The company holds 69 invention patents and 25 utility model patents, showcasing its technological capabilities in areas such as antibiotic alternatives and nutritional technology[48]. - Investment in R&D increased by 30% in 2022, focusing on innovative technologies and product development to enhance competitive advantage[148]. - The company is investing 300 million RMB in R&D for new technologies, focusing on AI and machine learning applications[165]. Risk Management - The company faces risks from cyclical fluctuations in the pig farming industry, which can impact overall performance if pig prices remain low[8]. - The company has implemented measures to mitigate risks associated with regulatory changes that could affect its customer base[14]. - The company has a comprehensive strategy to address potential risks from disease outbreaks in the pig farming sector, which could affect feed demand[11]. - The company has established a comprehensive internal control system that effectively manages operational risks and ensures compliance with relevant regulations[128]. Corporate Governance - The company has established a robust governance structure to ensure compliance and protect stakeholder interests[90]. - The company maintains financial independence with a complete financial management system and independent bank accounts[94]. - The company has a strong management team with diverse backgrounds, including the chairman and general manager who founded the company in 2006[101]. - The company emphasizes the importance of leadership and organizational development to drive future growth[85]. Employee and Social Responsibility - The company prioritizes employee rights, providing a supportive work environment and focusing on employee training and safety management[138]. - The company participates in social responsibility initiatives, including providing scholarships to support employees' children[141]. - The company contributes to poverty alleviation and rural revitalization by offering high-quality feed products and training to farmers[142]. Compliance and Transparency - The company guarantees that it will not engage in any business activities that directly or indirectly compete with its main business after the issuance and listing[154]. - The company will ensure compliance with commitments made in the prospectus and will compensate investors for any losses incurred due to non-compliance[169]. - The company will publicly disclose any reasons for not fulfilling commitments made in the prospectus and will apologize to shareholders if necessary[171]. - The company has committed to providing accurate and complete shareholder information in its public offering documents[166].
播恩集团:首次公开发行股票上市公告书
2023-03-05 12:38
股票简称:播恩集团 股票代码:001366 播恩集团股份有限公司 Boen Group CO., LTD. (江西省赣州经济技术开发区迎宾大道中段) 首次公开发行股票上市公告书 保荐人(主承销商) (上海市广东路 689 号) 二零二三年三月 1 特别提示 如无特别说明,本上市公告书中的简称或名词的释义与本公司首次公开发 行股票招股说明书中的相同。 公司股票将于 2023 年 3 月 7 日在深圳证券交易所主板上市。本公司提醒投 资者应充分了解股票市场风险及本公司披露的风险因素,在新股上市初期切忌 盲目跟风"炒新",应当审慎决策、理性投资。 2 第一节 重要声明与提示 播恩集团股份有限公司(以下简称"播恩集团"、"发行人"、"公司" 或"本公司")及全体董事、监事、高级管理人员保证上市公告书的真实性、 准确性、完整性,承诺上市公告书不存在虚假记载、误导性陈述或重大遗漏, 并依法承担法律责任。 深圳证券交易所、有关政府机关对本公司股票上市及有关事项的意见,均 不表明对本公司的任何保证。 本公司提醒广大投资者注意,凡本上市公告书未涉及的有关内容,请投资 者查阅刊载于巨潮资讯网(网址www.cninfo.com.c ...
播恩集团:首次公开发行股票发行结果公告
2023-02-27 13:06
播恩集团股份有限公司 首次公开发行股票发行结果公告 保荐机构(主承销商):海通证券股份有限公司 播恩集团股份有限公司(以下简称"播恩集团"、"发行人"或"公司")首次 公开发行不超过 4,035.00 万股人民币普通股(A 股)(以下简称"本次发行") 的申请已获中国证券监督管理委员会证监许可[2023]271 号文核准。本次发行的 保荐机构(主承销商)为海通证券股份有限公司(以下简称"海通证券"或"保荐 机构(主承销商)")。发行人的股票简称为"播恩集团",股票代码为"001366"。 本次发行采用网下向符合条件的投资者询价配售(以下简称"网下发行") 和网上向持有深圳市场非限售 A 股股份和非限售存托凭证市值的社会公众投资 者定价发行(以下简称"网上发行")相结合的方式进行。经发行人与保荐机构 (主承销商)综合考虑发行人所处行业、市场情况、同行业上市公司估值水平、 募集资金需求及承销风险等因素,协商确定本次股票发行价格为 9.32 元/股,发 行数量为 4,035.00 万股,全部为新股发行,无老股转让。 回拨机制启动前,网下初始发行数量为 2,421.00 万股,占本次发行数量的 60%;网上初始发行数 ...